For a case-control study of risk factors for renal cell carcinoma, a mailed questionnaire was used to collect data on 518 cases and 1,381 population-based controls in Ontario, Canada. Active cigarette smoking increased risk twofold among males (odds ratio estimate [OR]=2.0, 95 percent confidence interval (CI)=1.4–2.8) and females (OR=1.9, CI=1.3–2.6). Passive smoking appeared to increase risk somewhat among nonsmokers (males: OR=1.6, CI=0.5–4.7; females: OR=1.7, CI=0.8–3.4). A high Quetelet index (QI) was associated with a twofold increase in risk in both sexes, although this was based on reported weight at age 25 years for males (OR=1.9, CI=1.2–3.1) and five years prior to data collection for females (OR=2.5, CI=1.4–4.6). Diuretic use was associated with significantly increased risk among females, but not among males. Phenacetin use increased risk, while acetaminophen use was not associated with altered risk, although few subjects used either compound. Multiple urinary tract infections increased risk, but only significantly in females (OR=1.9, CI=1.2–2.9). Our data indicate the need for further exploration of passive smoking and diuretics as risk factors, as well as elucidation of mechanisms by which high lifetime QI and frequent urinary-tract infections might increase risk of this cancer.
Similar content being viewed by others
References
Clarke EA, Marrett LD, Kreiger N. The Ontario Cancer Registry: Twenty Years of Cancer Incidence, 1964–1983. Toronto, Ontario: The Ontario Cancer Treatment and Research Foundation Monograph #1, 1988.
World Health Organization, International Classification of Diseases, Ninth Revision, Geneva: WHO, 1977.
Dillman DA. Mail and Telephone Surveys: the Total Design Method. New York: John Wiley, 1978.
Marrett LD, Kreiger N, Dodds L, Hilditch S. The effect on response rates of offering a small incentive with a mailed questionnaire. Annals Epidemiol 1992: 2: 745–53.
Khosla T, Lowe CR. Indices of obesity derived from body weight and height. Br J Prev Soc Med 1967; 21: 122–8.
Compendium of Pharmaceuticals and Specialties. Canadian Pharmaceutical Association, 1968–1980: Editions 2–15.
Physicians Desk Reference. Montvale, NJ: 1967–1980: Editions 21–34.
Jhaveri S. Drug Notification Section, Drug Information Section, Drug Directorate of Health and Welfare Canada. Personal communication, August 1986.
Statistics and Epidemiology Research Corporation. EGRET (Epidemiologic Graphics Estimation and Testing), Version 0.26.6. Seattle, Washington SERC, 1991.
Royal Statistical Society. The Generalised Linear Interactive Modelling (GLIM) System Release 3.77. Oxford, UK: Numerical Algorithms Group Ltd, 1985.
Bennington JL, Laubscher FA. Epidemiologic studies on carcinoma of the kidney. I. Association of renal adenocarcinoma with smoking. Cancer 1968: 21: 1069–71.
Bennington JL, Ferguson BR, Campbell PB. Epidemiologic studies on earcinoma of the kidney. II. Association of renal adenoma with smoking. Cancer 1968; 22: 821–3.
Weir JW, Dunn JEJr. Smoking and mortality: A prospective study. Cancer 1970; 25: 105–12.
Wynder EL, Mabuchi K, Whitmore WFJr. Epidemiology of adenocarcinoma of the kidney. JNCI 1974; 53: 1619–34.
Armstrong B, Garrod A, Doll R. A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer 1976; 33: 127–36.
McLaughlin JK, Mandel JS, Blot WJ, et al. A populationbased case-control study of renal cell carcinoma. JNCI 1984; 72: 275–84.
Maclure M, Willet W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology 1990; 1: 430–40.
LaVecchia C, Negri E, D'Avanzo B, Franceschi S, Smoking and renal cell carcinoma. Cancer Research 1990; 5: 231–3.
Yu MC, Mack TM, Hanisch R, et al. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. JNCI 1986; 77: 351–6.
Asal NR, Geyer JR, Risser DR, et al. Risk factors in renal cell carcinoma: I. Methodology, demographics, tobacco, beverage use, and obesity. Cancer Detect Prev 1988; 11: 359–77.
McCredie M, Ford J, Stewart JH. Risk factors for cancer of the renal parenchyma. Int J Cancer 1988; 42: 13–6.
Brownson RC. A case-control study of renal cell carcinoma in relation to occupation, smoking, and alcohol consumption. Arch Environ Health 1988; 43: 238–41.
Sandler DP, Everson RB, Wilcox AJ, Passive smoking in adulthood and cancer risk. Am J Epidemiol 1985; 121: 37–48.
Bengtsson U, Angervall L, Ekman H, et al. Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 1968; 2: 145–50.
Bengtsson U, Angervall L. Analgesic abuse and tumours of the renal pelvis. Lancet 1970; i: 305.
Hoybe G, Nielsen OE. Renal pelvic carcinoma in phenacetin abusers. Scand J Urol Nephrol 1971; 5: 190–2.
McCredie M, Ford JM, Taylor JS, Stewart JH. Analgesics and cancer of the renal pelvis in New South Wales. Cancer 1982; 49: 2717–25.
McCredie M, Stewart JH, Ford JM, MacLennan RA. Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol 1983; 55: 220–4.
Johansson SL. Carcinogenicity of analgesics: Long term treatment of Sprague-Dawley rats with phenacetin, phenazone, ceffeine and paracetamol (acetaminophen). Int J Cancer 1981; 27: 521–9.
Maclure M, MacMahon B. Phenacetin and cancers of the urinary tract [Letter]. N Engl J Med 1985; 313: 1479.
Stolley PD. The risks of phenacetin use. N Engl J Med 1991; 324: 191–3.
Goodman MT, Morgenstern H, Wynder EL. A casecontrol study of factors affecting the development of renal cell cancer. Am J Epidemiol 1986; 124: 926–41.
Melman A, Grim G, Weinberger M. Increased incidence of renal cell carcinoma with hypertension. J Urol 1977; 118: 531–2.
Pillari G, Fulco JD, Lee W. Hypernephroma and hypertension. NY State J Med 1979; 79: 865–7.
McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 1992; 3: 323–31.
Mcllemgaard A, Moller H, Olsen JH. Diuretics may increase risk of renal cell carcinoma. Cancer Causes Control 1992; 3: 309–12.
McLaughlin JK, Blot WJ, Fraumeni JF. Diuretics and renal cell cancer. JNCI 1988; 80: 378.
Claude J, Kunse E, Frentzel-Beyme R, et al. Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 1986; 124: 578–89.
Jensen OM, Wahrendorf J, Knudsen JB, Sorensen BL. The Copenhagen case-control study of bladder cancer. II. Effect of coffee and other beverages. Int J Cancer 1986; 37: 651–7.
Slattery ML, West DW, Robinson LM. Fluid intake and bladder cancer in Utah. Int J Cancer 1988; 42: 17–22.
Kirkman H, Bacon RL. Estrogen-induced tumors of the kidney. I. Incidence of renal tumors in intact gonadectomized male golden hamsters treated with diethylstilbestrol. JNCI 1952; 13: 745–55.
Kirkman H, Bacon RL. Estrogen-induced tumors of the kidney. II. Effect of dose, administration, type of estrogen, and age on the induction of renal tumors in intact male golden hamsters. INCI 1952; 13: 757–71.
Ward DN, Putch JD, McGregor RF, et al. Estrogeninduced kidney tumors in the Golden hamster. II. Diethylstilbestrol absorption and distribution in tissues. Cancer Res 1964; 24: 319–27.
Reznik-Schuller H. Carcinogenic effects of diethylstilbestrol in male Syrian Golden hamsters and European hamsters. JNCI 1979; 62: 1083–8.
Li JJ, Li SA, Klicka JK, et al. Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res 1983; 43: 5200–4.
Bellett RE, Squitieri AP. Estrogen-induced hypernephroma. J Urol 1974; 112: 160–1.
Nissenkorn I, Servadio C, Avidor I. Oestrogen-induced renal carcinoma. Br J Urol 1979; 51: 6–9.
Li SA, Li JJ. Estrogen-induced progesterone receptor in the Syrian hamster kidney. I. Modulation by antiestrogens and androgens. Endocrinology 1978; 103: 2119–28.
Li JJ, Cuthbertson TL, Li SA. Inhibition of estrogen tumorigenesis in the Syrian Golden hamster kidney by antiestrogens. JNCI 1980; 64: 795–800.
Li JJ, Li SA. Estrogen-induced progesterone receptor in the Syrian hamster kidney. II. Modulation by synthetic progestins. Endocrinology 1981; 108: 1751–6.
Potter JD, McMichael AJ. Large bowel cancer in women in relation to reproductive and hormonal factors: A casecontrol study. JNCI 1983; 71: 703–9.
Davis FG, Furner SE, Persky V, Koch M. The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer 1989; 43: 587–90.
Weiss NS, Daling JR, Chow WH. Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. INCI 1981; 67: 57–60.
Howe GR, Craib KJP, Miller AB. Age at first pregnancy and risk of colorectal cancer: A case-control study. INCI 1985; 74: 1155–9.
Miller AB, Barcley THC, Choi NW, et al. A study of cancer, parity and age at first pregnancy. J Chron Dis 1980; 33: 595–605.
Additional information
Des Kreiger, Marrett, and Darlington are with the Department of Preventive Medicine and Biostatistics, University of Toronto, and Division of Epidemiology and Statistics, Ontario Cancer Treatment and Research Foundation, Canada. Dr Dodds is with the Keproductive Care Program of Nova Scotia, formerly of the Ontario Cancer Treatment and Research Foundation, Canada. Ms Hilditch is with the Ontario Cancer Treatment and Research Foundation Epidemiology Research Unit, University of Toronto, Canada. Address correspondence to Dr Kreiger Department of Preventive Medicine and Biostatistics, 12 Queen's Park Crescent West, 3rd Floor, McMurrich Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada. This study was funded by a grant #01692 of the Ontario Ministry of Health.
Rights and permissions
About this article
Cite this article
Kreiger, N., Marrett, L.D., Dodds, L. et al. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 4, 101–110 (1993). https://doi.org/10.1007/BF00053150
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00053150